BELGRADE, Mont., Sept. 12, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces John Deedrick has joined Bacterin's board of directors effective September 6, 2012. With this addition, the board will have six members.
Mr. Deedrick is an experienced senior executive with 15 years experience in healthcare venture capital and business consulting. Mr. Deedrick also has 12 years of experience in the high tech defense industry. He has served as a corporate venture capitalist for Mayo Clinic and a Founder and General Partner for Accuitive Medical Ventures. Mr. Deedrick also serves as President and CEO of CHIP Solutions and is Founder and Chairman of GreatDeeds, a Minnesota non-profit organization. Mr. Deedrick has served on the board of numerous early stage healthcare companies over the last 15 years.
"John brings to our board strong skills in the area of health care operations, growing early stage life science companies, and the use of information technology to improve operating effectiveness," said Guy Cook, Bacterin's CEO. "We are pleased to have him join us."
Mr. Deedrick received his undergraduate degree from Northwestern College ( Roseville, MN) and his MBA from St. Thomas University ( St. Paul, MN).About Bacterin International Holdings Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.